Accepted at 1:02 a.m. Nov, 01, 2023 by God_Have_MRSA
Author: shmuelsash
Related Note: 1463675586235
Rationale for change

Source be79a813-d52c-4945-98ca-8cbe821386ad

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::09_Plasma_Cell_Disorders #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::04_Parathyroid::04_Unhealthy_Bone #AK_Step2_v12::#Resources_by_rotation::FM::casefiles::osteoporosis #AK_Step2_v12::Original_decks::Dorian::fam::casefiles::osteoporosis #AK_Step1_v12::#AMBOSS::ROalHk #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::06_Bisphosphonates_Denosumab_Teriparatide #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::*Denosumab #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#Bootcamp::Musculoskeletal::02_Non-Rheumatologic_Disease::06_Osteoporosis #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::03_Thyroid,_Parathyroid,_Adrenal::02_Bisphosphonates,_Raloxifene,_Denosumab,_Calcitonin #AK_Step1_v12::#UWorld::COMLEX::26022 #AK_Step1_v12::#B&B::15_MSK::03_Pathology::03_Osteoporosis_Drugs #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::*Denosumab #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::04_Parathyroid::04_Unhealthy_Bone #AK_Step2_v12::#AMBOSS::CK0qiS #AK_Step1_v12::#UWorld::Step::14930 #AK_Step2_v12::#Subjects::Orthopedics_&_Rheumatology::02_Pathology::01_Bone::Osteoporosis::Management #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step2_v12::#B&B::04_Endocrinology::04_Other::04_Osteoporosis::Extra #AK_Step1_v12::#AMBOSS::rZaf1Q